Monitor SEDAR+ for the detailed voting results and any follow-up announcement regarding the mechanics and ratio of the share consolidation, which could affect liquidity and investor perception given the company's $2M market cap.
Price Chart
Executive Summary
XORTX Therapeutics held its annual and special meeting of shareholders on March 24, 2026, where all proposed items were approved, including the re-election of five directors, auditor appointment, executive compensation, stock option plan re-approval, and a share consolidation. The filing is administrative in nature and contains no new financial or clinical data.
Key Facts
- Annual and special shareholder meeting held on March 24, 2026
- Approximately 35% of outstanding shares were represented
- All proposals approved: board re-election, auditor appointment, director remuneration, stock option plan, and share consolidation
- No financial results, clinical updates, or material operational changes disclosed
- Share consolidation requires further details for implementation and market impact
Financial Impact
Not specified
Risk Factors
- Share consolidation could lead to increased volatility or reduced liquidity if not well-communicated
- Lack of material operational updates may limit near-term catalysts for the stock
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-001979 |
| Document: f6k_032726.htm | 0001171843-26-001979 |
| Document: 0001171843-26-001979-index-headers.html | 0001171843-26-001979 |
| Document: 0001171843-26-001979-index.html | 0001171843-26-001979 |
| Document: 0001171843-26-001979.txt | 0001171843-26-001979 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 6-K | $1.41 | awaiting T+20 | — | $1.06 (−24.82%) |
Sep 18, 2026 5w ago | 6-K | $1.92 $1.24 | ▼ −35.42% | ▼ −35.62% | $1.06 (−44.79%) |
Sep 18, 2026 5w ago | Press Release | $1.92 $1.24 | ▼ −35.42% | ▼ −35.62% | $1.06 (−44.79%) |
Sep 4, 2026 7w ago | 6-K | $2.31 $1.70 | ▲ +26.41% | ▲ +27.01% | $1.06 (+54.11%) |
Aug 28, 2026 8w ago | 6-K | $2.34 $1.71 | ▼ −26.86% | ▼ −27.12% | $1.06 (−54.66%) |
Aug 3, 2026 11w ago | 6-K | $2.16 $2.16 | · 0.00% | ▲ +1.24% | $1.06 (−50.93%) |
Jul 29, 2026 12w ago | 6-K | $2.06 $2.22 | ▲ +7.67% | ▲ +2.65% | $1.06 (−48.54%) |
Jun 15, 2026 19w ago | 6-K | $2.19 $2.03 | ▼ −7.31% | ▼ −6.56% | $1.06 (−51.60%) |
Jun 12, 2026 19w ago | 6-K | $2.19 $2.03 | ▼ −7.31% | ▼ −6.56% | $1.06 (−51.60%) |
May 19, 2026 22w ago | 6-K / PRESS-RELEASE | $2.32 $2.15 | ▲ +7.33% | ▲ +8.31% | $1.06 (+54.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers